ASX
Prescient Therapeutics Limited
PTX:ASX•Healthcare
Sensitive ASX Announcement
PTX to resume Clinical Trial of PTX-200 in Ovarian Cancer
Published: 06/11/17, 08:47am (AEST)•3 pages